Fabian Finkelmeier (F Finkelmeier)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 49

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Journal of cancer research and clinical oncology

Alimentary pharmacology & therapeutics

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Simon Bernatz, Falko Schulze, Julia Bein, Katrin Bankov, Scherwin Mahmoudi, Leon D Grünewald, Vitali Koch, Angelika Stehle, Andreas A Schnitzbauer, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Thomas J Vogl, Peter J Wild, Maximilian N Kinzler
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures. Journal of cancer research and clinical oncology 150 (7) (2024)
Simon Bernatz, Falko Schulze, Julia Bein, Katrin Bankov, Scherwin Mahmoudi, Leon D Grünewald, Vitali Koch, Angelika Stehle, Andreas A Schnitzbauer, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Thomas J Vogl, Peter J Wild, Maximilian N Kinzler
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures. Journal of cancer research and clinical oncology 150 (7) (2024)
Katharina Mitzlaff, Martha M Kirstein, Christian Müller, Marino Venerito, Alexander Olkus, Michael T Dill, Arndt Weinmann, Lorenz Kocheise, Alina Busch, Kornelius Schulze, Gabriel Allo, Dirk-Thomas Waldschmidt, Maryam Barsch, Bertram Bengsch, Michael Quante, Maria A Gonzalez-Carmona, Vera Himmelsbach, Fabian Finkelmeier, Roman Kloeckner, Peter Schirmacher, Jens-Uwe Marquardt, Carolin Czauderna
Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort. United European gastroenterology journal (2024)
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I Keller, Anthony Fullam, Laura Altepeter, Victoria T Mücke, Fabian Finkelmeier, Katharina M Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A J Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernandez, Jonel Trebicka, null null
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (7) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I Keller, Anthony Fullam, Laura Altepeter, Victoria T Mücke, Fabian Finkelmeier, Katharina M Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A J Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernandez, Jonel Trebicka, null null
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics (2024)
Simon Bernatz, Falko Schulze, Julia Bein, Katrin Bankov, Scherwin Mahmoudi, Leon D Grünewald, Vitali Koch, Angelika Stehle, Andreas A Schnitzbauer, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Thomas J Vogl, Peter J Wild, Maximilian N Kinzler
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures. Journal of cancer research and clinical oncology 150 (7) (2024)
Simon Bernatz, Falko Schulze, Julia Bein, Katrin Bankov, Scherwin Mahmoudi, Leon D Grünewald, Vitali Koch, Angelika Stehle, Andreas A Schnitzbauer, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Thomas J Vogl, Peter J Wild, Maximilian N Kinzler
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures. Journal of cancer research and clinical oncology 150 (7) (2024)
Vera Himmelsbach, Matthias Jeschke, Christian M Lange, Bernhard Scheiner, Matthias Pinter, Friedrich Sinner, Marino Venerito, Alexander Queck, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Cancers 16 (13) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver (2024)
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I Keller, Anthony Fullam, Laura Altepeter, Victoria T Mücke, Fabian Finkelmeier, Katharina M Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A J Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernandez, Jonel Trebicka, null null
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (7) (2024)
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I Keller, Anthony Fullam, Laura Altepeter, Victoria T Mücke, Fabian Finkelmeier, Katharina M Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A J Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernandez, Jonel Trebicka, null null
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (7) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Vera Himmelsbach, Christine Koch, Jörg Trojan, Fabian Finkelmeier
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions? Journal of hepatocellular carcinoma 11 (2024)
Michael Basic, Keerthihan Thiyagarajah, Mirco Glitscher, Anja Schollmeier, Qingyan Wu, Esra Görgülü, Pia Lembeck, Jannik Sonnenberg, Julia Dietz, Fabian Finkelmeier, Michael Praktiknjo, Jonel Trebicka, Stefan Zeuzem, Christoph Sarrazin, Eberhard Hildt, Kai-Henrik Peiffer
Impaired HBsAg release and antiproliferative/antioxidant cell regulation by HBeAg-negative patient isolates reflects an evolutionary process. Liver international : official journal of the International Association for the Study of the Liver (2024)
Vera Himmelsbach, Matthias Jeschke, Christian M Lange, Bernhard Scheiner, Matthias Pinter, Friedrich Sinner, Marino Venerito, Alexander Queck, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
Systemic Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Multicenter Trial. Cancers 16 (13) (2024)
Florian Alexander Michael, Michael Jung, Mike Reimers, Clara Oschwald, Ulrike Mihm, Christoph Welsch, Dirk Walter, Fabian Finkelmeier, Johannes Masseli, Anita Pathil, Georg Dultz, Danuta Puhlmann, Laura Diaz-Martinez, Daniel Hack, Neelam Lingwal, Joerg Bojunga, Volkhard A J Kempf, Stefan Zeuzem, Mireen Friedrich-Rust
A new drying method of thermolabile flexible endoscope channels by laminar and turbulent airflow - a prospective, randomized-controlled, single-center, proof-of-concept trial. The American journal of gastroenterology (2024)
Marcus M Mücke, María Hernández-Tejero, Wenyi Gu, Michael Kuhn, Malte Janz, Marisa I Keller, Anthony Fullam, Laura Altepeter, Victoria T Mücke, Fabian Finkelmeier, Katharina M Schwarzkopf, Carla Cremonese, Peter-Merton Hunyady, Myriam W Heilani, Frank Erhard Uschner, Robert Schierwagen, Maximilian J Brol, Julia Fischer, Sabine Klein, Kai-Henrik Peiffer, Michael Hogardt, Saeed Shoaie, Minneke J Coenraad, Jörg Bojunga, Vicente Arroyo, Stefan Zeuzem, Volkhard A J Kempf, Christoph Welsch, Wim Laleman, Peer Bork, Javier Fernandez, Jonel Trebicka, null null
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis. Alimentary pharmacology & therapeutics 59 (7) (2024)
Vera Himmelsbach, Christine Koch, Jörg Trojan, Fabian Finkelmeier
Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions? Journal of hepatocellular carcinoma 11 (2024)
Simon Bernatz, Falko Schulze, Julia Bein, Katrin Bankov, Scherwin Mahmoudi, Leon D Grünewald, Vitali Koch, Angelika Stehle, Andreas A Schnitzbauer, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Thomas J Vogl, Peter J Wild, Maximilian N Kinzler
Small duct and large duct type intrahepatic cholangiocarcinoma reveal distinct patterns of immune signatures. Journal of cancer research and clinical oncology 150 (7) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, Virginia Genovesi, Maria Caterina De Grandis, Massimo Iavarone, Fabio Marra, Francesco Foschi, Emiliano Tamburini, Federico Rossari, Francesco Vitiello, Linda Bartalini, Caterina Soldà, Francesco Tovoli, Caterina Vivaldi, Sara Lonardi, Marianna Silletta, Takashi Kumada, Naoya Sakamoto, Hideki Iwamoto, Tomoko Aoki, Vera Himmelsbach, Margarida Montes, Atsushi Hiraoka, Takuya Sho, Takashi Niizeki, Naoshi Nishida, Christoph Steup, Masashi Hirooka, Kazuya Kariyama, Joji Tani, Masanori Atsukawa, Koichi Takaguchi, Ei Itobayashi, Shinya Fukunishi, Kunihiko Tsuji, Toru Ishikawa, Kazuto Tajiri, Hironori Ochi, Satoshi Yasuda, Hidenori Toyoda, Chikara Ogawa, Takashi Nishimura, Takeshi Hatanaka, Satoru Kakizaki, Noritomo Shimada, Kazuhito Kawata, Fujimasa Tada, Hideko Ohama, Kazuhiro Nouso, Akihiro Morishita, Akemi Tsutsui, Takuya Nagano, Norio Itokawa, Tomomi Okubo, Taeang Arai, Michitaka Imai, Hisashi Kosaka, Atsushi Naganuma, Yohei Koizumi, Shinichiro Nakamura, Masaki Kaibori, Hiroko Iijima, Yoichi Hiasa, Mara Persano, Silvia Camera, Silvia Foti, Luca Aldrighetti, Stefano Cascinu, Andrea Casadei-Gardini, Piscaglia Fabio
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver 44 (5) (2024)
Maximilian N Kinzler, Katrin Bankov, Julia Bein, Claudia Döring, Falko Schulze, Henning Reis, Scherwin Mahmoudi, Vitali Koch, Leon D Grünewald, Angelika Stehle, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Peter J Wild, Thomas J Vogl, Simon Bernatz
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE. Current oncology (Toronto, Ont.) 30 (3) (2023)
Maximilian N Kinzler, Jan Jeroch, Christina Klasen, Vera Himmelsbach, Christine Koch, Fabian Finkelmeier, Jörg Trojan, Stefan Zeuzem, Ursula Pession, Henning Reis, Melanie C Demes, Peter J Wild, Dirk Walter
Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center. Journal of cancer research and clinical oncology (2023)
Maximilian N Kinzler, Katrin Bankov, Julia Bein, Claudia Döring, Falko Schulze, Henning Reis, Scherwin Mahmoudi, Vitali Koch, Leon D Grünewald, Angelika Stehle, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Peter J Wild, Thomas J Vogl, Simon Bernatz
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE. Current oncology (Toronto, Ont.) 30 (3) (2023)
Sebastian E Koschade, Jan A Stratmann, Björn Steffen, Shabnam Shaid, Fabian Finkelmeier, Hubert Serve, Wolfgang Miesbach, Christian H Brandts, Olivier Ballo
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy. European journal of haematology 110 (4) (2023)
Florian Alexander Michael, Mireen Friedrich-Rust, Hans-Peter Erasmus, Christiana Graf, Olivier Ballo, Mate Knabe, Dirk Walter, Christoph D Steup, Marcus Maximilian Mücke, Victoria Therese Mücke, Kai H Peiffer, Esra Görgülü, Antonia Mondorf, Wolf Otto Bechstein, Natalie Filmann, Stefan Zeuzem, Jörg Bojunga, Fabian Finkelmeier
Treatment of Non-Anastomotic Biliary Strictures after Liver Transplantation: How Effective Is Our Current Treatment Strategy? Journal of clinical medicine 12 (10) (2023)
Claire Conche, Fabian Finkelmeier, Marina Pešić, Adele M Nicolas, Tim W Böttger, Kilian B Kennel, Dominic Denk, Fatih Ceteci, Kathleen Mohs, Esther Engel, Özge Canli, Yasamin Dabiri, Kai-Hendrik Peiffer, Stefan Zeuzem, Gabriela Salinas, Thomas Longerich, Huan Yang, Florian R Greten
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut (2023)
Philip G Ferstl, Katharina Bremer, Natalie Filmann, Volkhard A J Kempf, Michael Hogardt, Olivier Ballo, Fabian Finkelmeier, Jonel Trebicka, Stefan Zeuzem, Jörg Bojunga, Mireen Friedrich-Rust, Dirk Walter
Short Versus Long Antibiotic Therapy and Risk of Recurrence of Acute Cholangitis Due to Malignant Biliary Strictures. Journal of clinical medicine 12 (21) (2023)
Sebastian E Koschade, Laura M Moser, Artur Sokolovskiy, Florian Alexander Michael, Hubert Serve, Christian H Brandts, Fabian Finkelmeier, Stefan Zeuzem, Jonel Trebicka, Philip Ferstl, Olivier Ballo
Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia. Journal of clinical medicine 12 (13) (2023)
Maximilian N Kinzler, Katrin Bankov, Julia Bein, Claudia Döring, Falko Schulze, Henning Reis, Scherwin Mahmoudi, Vitali Koch, Leon D Grünewald, Angelika Stehle, Dirk Walter, Fabian Finkelmeier, Stefan Zeuzem, Peter J Wild, Thomas J Vogl, Simon Bernatz
CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE. Current oncology (Toronto, Ont.) 30 (3) (2023)
Sebastian E Koschade, Jan A Stratmann, Björn Steffen, Shabnam Shaid, Fabian Finkelmeier, Hubert Serve, Wolfgang Miesbach, Christian H Brandts, Olivier Ballo
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy. European journal of haematology 110 (4) (2023)
Sebastian E Koschade, Jan A Stratmann, Björn Steffen, Shabnam Shaid, Fabian Finkelmeier, Hubert Serve, Wolfgang Miesbach, Christian H Brandts, Olivier Ballo
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy. European journal of haematology 110 (4) (2023)
Katrin Bankov, Falko Schulze, Steffen Gretser, Henning Reis, Nada Abedin, Fabian Finkelmeier, Jörg Trojan, Stefan Zeuzem, Andreas A Schnitzbauer, Dirk Walter, Peter J Wild, Maximilian N Kinzler
Active Autophagy Is Associated with Favorable Outcome in Patients with Surgically Resected Cholangiocarcinoma. Cancers 15 (17) (2023)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Sebastian E Koschade, Jan A Stratmann, Björn Steffen, Shabnam Shaid, Fabian Finkelmeier, Hubert Serve, Wolfgang Miesbach, Christian H Brandts, Olivier Ballo
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy. European journal of haematology (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Mueller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Boemmel
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens (Basel, Switzerland) 12 (1) (2022)
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Mueller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Boemmel
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens (Basel, Switzerland) 12 (1) (2022)
Vera Himmelsbach, Matthias Pinter, Bernhard Scheiner, Marino Venerito, Friedrich Sinner, Carolin Zimpel, Jens U Marquardt, Jörg Trojan, Oliver Waidmann, Fabian Finkelmeier
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers. Cancers 14 (7) (2022)
Maximilian N Kinzler, Angelika Stehle, Falko Schulze, Michael Hogardt, Thomas A Wichelhaus, Volkhard A J Kempf, Fabian Finkelmeier, Jörg Trojan, Stefan Zeuzem, Andreas A Schnitzbauer, Wolf O Bechstein, Peter J Wild, Dirk Walter
Colonization with multidrug-resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver (2022)
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Mueller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Boemmel
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens (Basel, Switzerland) 12 (1) (2022)
Michael Basic, Alica Kubesch, Lisa Kuhnhenn, Esra Görgülü, Fabian Finkelmeier, Julia Dietz, Mate Knabe, Victoria T Mücke, Marcus Maximilian Mücke, Annemarie Berger, Stefan Zeuzem, Christoph Sarrazin, Eberhard Hildt, Kai-Hendrik Peiffer
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Victoria Therese Mücke, Dominique Thomas, Marcus Maximilian Mücke, Oliver Waidmann, Stefan Zeuzem, Christoph Sarrazin, Josef Pfeilschifter, Johannes Vermehren, Fabian Finkelmeier, Georgios Grammatikos
Serum sphingolipids predict de novo hepatocellular carcinoma in hepatitis C cirrhotic patients with sustained virologic response. Liver international : official journal of the International Association for the Study of the Liver 39 (11) (2019)
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, Fabian Finkelmeier, Kornelius Schulze, Johann von Felden, Sandra Koch, Philipp Schwabl, Jan B Hinrichs, Fredrik Waneck, Oliver Waidmann, Thomas Reiberger, Christian Müller, Wolfgang Sieghart, Michael Trauner, Arndt Weinmann, Henning Wege, Jörg Trojan, Markus Peck-Radosavljevic, Arndt Vogel, Matthias Pinter
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort. Alimentary pharmacology & therapeutics 49 (10) (2019)
L Kuhnhenn, B Jiang, A Kubesch, Johannes Vermehren, Viola Knop, S Susser, J Dietz, G Carra, Fabian Finkelmeier, G Grammatikos, S Zeuzem, C Sarrazin, E Hildt, Kai-Hendrik Peiffer
Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection. Alimentary pharmacology & therapeutics 47 (11) (2018)
Fabian Finkelmeier, Carolin Czauderna, Lukas Perkhofer, Thomas J Ettrich, Jörg Trojan, Arndt Weinmann, Jens U Marquardt, Johannes Vermehren, Oliver Waidmann
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers. Journal of cancer research and clinical oncology 145 (1) (2018)
Fabian Finkelmeier, Özge Canli, Kai-Henrik Peiffer, Dirk Walter, Andrea Tal, Christine Koch, Ursula Pession, Johannes Vermehren, Jörg Trojan, Stefan Zeuzem, Albrecht Piiper, Florian R Greten, Georgios Grammatikos, Oliver Waidmann
Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis. PloS one 13 (7) (2018)

Fabian Finkelmeier.css-eqlu8i{font-size:small;padding-left:4px;} (F Finkelmeier)

Publication Activity (10 Years)

Top Topics

Top Venues

Fabian Finkelmeier (F Finkelmeier)